GPT-Rosalind (OpenAI) vs Llama 4 (Meta)
Which one should you pick? Here's the full breakdown.
GPT-Rosalind (OpenAI)
OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)
Llama 4 (Meta)
Meta's open-weights flagship family -- Scout (10M context), Maverick (multimodal 400B MoE), Behemoth in preview
| Category | GPT-Rosalind (OpenAI) | Llama 4 (Meta) |
|---|---|---|
| Ease of Use | 3.0 | 5.0 |
| Output Quality | 9.0 | 8.5 |
| Value | 7.0 | 9.0 |
| Features | 8.0 | 9.0 |
| Overall | 6.8 | 7.9 |
Pricing Comparison
| Feature | GPT-Rosalind (OpenAI) | Llama 4 (Meta) |
|---|---|---|
| Free Tier | No | Yes |
| Starting Price | Invite only | $0 |
Benchmark Head-to-Head
Llama 4 Maverick (17B/400B MoE) benchmarks — GPT-Rosalind (OpenAI) has no published benchmarks
| Benchmark | Description | Score |
|---|---|---|
| MMLU-Pro | Harder multi-subject reasoning | 80.5% |
| GPQA Diamond | Graduate-level science questions | 69.8% |
| HumanEval | Python code generation | 88% |
| MMMU (multimodal) | 73.4% |
Which Should You Pick?
Pick GPT-Rosalind (OpenAI) if...
Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.
Visit GPT-Rosalind (OpenAI)Pick Llama 4 (Meta) if...
- ✓Easier to use (5 vs 3)
- ✓Better value for money (9/10)
- ✓More features (9 vs 8)
- ✓Has a free tier
Developers and teams who need a permissively-licensed open-weights model with strong tooling, long context (Scout), or multimodal (Maverick). Safe default choice given the ecosystem.
Visit Llama 4 (Meta)Our Verdict
Llama 4 (Meta) is the clear winner here with 7.9/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but Llama 4 (Meta) outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.